Boji Medical Stock Soars 8.56%, Hits Intraday High of CNY 9.16

Boji Medical Technology Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.56% on June 29, 2026. The stock reached an intraday high of CNY 9.16, marking a notable achievement for the small-cap company in the Pharmaceuticals & Biotechnology sector. In terms of performance metrics, Boji Medical has shown resilience with a 1.12% increase over the past year, despite a challenging broader market environment. The company's net sales for the quarter reached CNY 220.16 million, reflecting a robust growth rate of 58.54%. Additionally, Boji Medical reported a remarkable 322.01% increase in net profit as of March 26, showcasing its operational efficiency. The company also boasts a strong operating cash flow of CNY 69.93 million and an impressive inventory turnover ratio of 3.11 times, indicating effective management of resources. With a return on equity of 3.99% and a price-to-book ratio of 1.22, Boji Medical maintains a fair valuation in the current market landscape. Overall, the stock's performance today highlights its potential within the industry.